Assessment
glofitamab
Relapsed or refractory diffuse large B-cell lymphoma NOS (DLBCL NOS), not eligible for autologous stem cell transplantation
- Modules
- IQWiG assessments · G-BA decisions
- Connections
- 2
Connected evidence
2 relationsAssessment
Relapsed or refractory diffuse large B-cell lymphoma NOS (DLBCL NOS), not eligible for autologous stem cell transplantation
Connected evidence
2 relations